期刊文献+

正丁胺对人肝癌细胞Bel-7402增殖的影响

Effects of N-Butylamine on the Proliferation of Human Bel-7402 Hepatocarcinoma Cell Line
下载PDF
导出
摘要 目的研初步检测正丁胺作用下人肝癌Bel-7402细胞的增殖情况。方法体外培养人肝细胞癌Bel-7402细胞,予不同浓度正丁胺进行干预作为正丁胺干预组,无药物组作为空白对照组。绘制细胞生长曲线,并利用MTT体外检测法探讨该药物对Bel-7402细胞的半致死量,进行了初步的体外活性评价。结果较低浓度的正丁胺能够促进肿瘤细胞增殖,正丁胺浓度高于2 mmol/L时,细胞增殖速度减缓。结论当正丁胺达到一定浓度时才具有一定的体外肿瘤生长抑制作用。 Objective To investigate the effects of n-Butylamine in human hepatocellular carcinoma Bel-7402 cells. Methods Human hepatocellular cancer Bel-7402 cells were cultured in vitro, they were treated with diferent concentrations of n-Butylamine as trial group and without n-Butylamine as control group. Cell growth curve was done, and the cell viability was measured by MTT assay. Results Promoting Bel-7402 proliferation when the n-butylamine at lower concentrations, cell proliferation slowed down when the concentrations of n-butylamine was higher than 2mmol/L. Conclusion N-Butylamine reaches a certain concentration can inhibit the growth of tumor in vitro.
作者 陆琼 马玲
出处 《中国继续医学教育》 2015年第9期202-203,共2页 China Continuing Medical Education
关键词 正丁胺 肝癌细胞 细胞增殖 N-Butylamine Hepatocelluar carcinoma cell Proliferation
  • 相关文献

参考文献4

二级参考文献24

  • 1赵莲华,李清,林芃,李坤,陈咏梅,高乐,张宁宁,李密.黄芪多糖协同顺铂对BEL-7404人肝癌细胞的杀伤作用[J].实用癌症杂志,2005,20(1):34-35. 被引量:44
  • 2William P, McGuire MD,William J,et al.Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage Ⅲ and Stage IV ovarian Cancer[J].N Engl J Med,1996,334 (1):1-6.
  • 3Zhou X D, Tang Z Y, Yang B H, et al. Experience of 1000 patients who underwent hepatectomy for small hep- atocellular carcinoma [ J ]. Cancer, 2001, 91 8) : 1479-1486.
  • 4Yang J M, Kan T, Chen H, et al. Hepatectomy m the treatment of very big primary liver cancer:report of 86cases [ J ]. Hepatobiliary Pancreat Dis Int, 2002, 1 (1) : 42-45.
  • 5Pignata S, Daniele B, Gallo C, et al. Endocrine treat- ment of hepatocellular carcinoma, any evidence of bene- fit[J]. EurJCancer, 1998, 34(1): 25-32.
  • 6Urasaki Y, Ueda T, Yoshida A, et al. Establishment of a daunorubicin-resistant cell line which shows multi-drug resistance by multifactorial mechanisms [ J ]. Anticancer Res, 1996, 16(2):709-714.
  • 7Yang L Y, Trujillo J M. Biological characterization of multidrug-resistant human colon carcinoma sublines in- duced/selected by two methods [ J ]. Cancer Res, 1990, 50: 3218-3225.
  • 8Gottesman M M, Fojo T, Bates S E. Muhidrug-resist- ance in cancer: role of ATP- dependent transporters [J]. Cancer, 2002, 2(1): 45-48.
  • 9Sun Y L, Zhou G Y, Li K N, et al. Suppression of glu- cosyceramide synthase by RNA interference reverses multidrug resistance in human breast cancer cells [ J ]. Neoplasma, 2006, 53 ( 1 ) : 1-8.
  • 10Ejendal K F, Hrycyna C A. Multidrug resistance and cancer: the role of the human ABC transporter ABC G2 [ J ]. Curt Protein Pept Sci, 2002, 3 (5) : 503- 511.

共引文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部